Kyle Lakin
19 Mar 2024
AstraZeneca acquires Fusion Pharmaceuticals for $2.4 billion, bolstering oncology portfolio with radioconjugate innovations
Showing 1 to 1 of 1 entries
Case 132 | Deals 336
Case 106 | Deals 325
Case 140 | Deals 319
Case 229 | Deals 304
Case 78 | Deals 232
25 Feb 2025
17 Feb 2025
22 Jan 2025
21 Jan 2025